Management of Cytokine Release Syndrome (CRS) and HLH
Related Research units
Abstract
Cytokine release syndrome (CRS) is caused by a rapid and mild to massive release of cytokines from immune cells involved in immune reactions, particularly after immunotherapy. The frequency and severity of CRS after CAR-T cell therapy varies between products (any grade: 37–93%, G3/4: 1–23%) (Neelapu et al. 2017; Schuster et al. 2019; Abramson et al. 2020).
Bibliographical data
| Original language | English |
|---|---|
| Title of host publication | The EBMT/EHA CAR-T Cell Handbook |
| Editors | Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele |
| REQUIRED books only: Number of pages | 5 |
| Place of Publication | Cham |
| Publisher | Springer International Publishing |
| Publication date | 2022 |
| Edition | 1 |
| Pages | 135-139 |
| ISBN (Print) | 978-3-030-94352-3 |
| ISBN (Electronic) | 978-3-030-94353-0 |
| DOIs | |
| Publication status | Published - 2022 |
